Similar Items: Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?
- Association of Sodium‐Glucose Cotransporter 2 Inhibitors Treatment With Contrast‐Induced Acute Kidney Injury in Older Adults With T2D and CKD: A Propensity Matched Analysis
- Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
- Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
- Heart starts suffering early in sickle cell disease
- Resistance Training in Cardiovascular Diseases: A Review on Its Effectiveness in Controlling Risk Factors
- Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia